Cargando…
Correction: EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
Autores principales: | Wang, Xuemin, Jiang, Pan, Wang, Pengqi, Yang, Chung S., Wang, Xuerong, Feng, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488307/ https://www.ncbi.nlm.nih.gov/pubmed/26121483 http://dx.doi.org/10.1371/journal.pone.0132086 |
Ejemplares similares
-
EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
por: Wang, Xuemin, et al.
Publicado: (2015) -
NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells
por: Jiang, Pan, et al.
Publicado: (2016) -
Integrin αV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1
por: Lin, Xinjian, et al.
Publicado: (2014) -
Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2023) -
Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals
por: Liang, Zheng Dong, et al.
Publicado: (2013)